Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasms 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Gastrointestinal Neoplasms 1

Interventions

Paclitaxel 69 Bevacizumab 63 Carboplatin 53 pembrolizumab 46 olaparib 33 Specimen Handling 27 Gemcitabine 27 Cyclophosphamide 26 Magnetic Resonance Spectroscopy 24 liposomal doxorubicin 22 Cisplatin 21 niraparib 20 Taxes 18 Nivolumab 18 fludarabine 17 Topotecan 17 Biopsy 17 Doxorubicin 14 Immunoglobulin G 12 Fulvestrant 12 Disulfides 12 durvalumab 10 Oxaliplatin 10 aldesleukin 9 Surveys and Questionnaires 9 Ipilimumab 9 Fluorouracil 9 Blood Specimen Collection 9 mirvetuximab soravtansine 8 cemiplimab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Glutamyl Aminopeptidase × 1 year × Clear all

NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡